{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T07:46:21Z","timestamp":1724053581933},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.vph.2016.09.001","type":"journal-article","created":{"date-parts":[[2016,9,9]],"date-time":"2016-09-09T15:06:08Z","timestamp":1473433568000},"page":"121-128","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gene expression profiling of calcium-channel antagonists in the heart of hypertensive and normotensive rats reveals class specific effects"],"prefix":"10.1016","volume":"87","author":[{"given":"Carolin","family":"Zwadlo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Borlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2016.09.001_bb0005","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Mancia","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.vph.2016.09.001_bb0010","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2016.09.001_bb0015","article-title":"Ca(2+)-dependent mechanisms of cytotoxicity and programmed cell death","volume":"64\u201365","author":"Orrenius","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.vph.2016.09.001_bb0020","first-page":"1","article-title":"The calcium ion and cell death","volume":"43","author":"Orrenius","year":"1994","journal-title":"J. Neural Transm. Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.vph.2016.09.001_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1289\/ehp.99107s125","article-title":"Calcium signaling and cytotoxicity","volume":"107","author":"Kass","year":"1999","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.vph.2016.09.001_bb0030","series-title":"Kalziumantagonisten-Handbuch: Pharmakologie und Klinik","year":"2002"},{"key":"10.1016\/j.vph.2016.09.001_bb0035","series-title":"Drug Class Review on Calcium Channel Blockers: Final Report [Internet]","author":"McDonagh","year":"2005"},{"key":"10.1016\/j.vph.2016.09.001_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.hlc.2004.02.002","article-title":"Diltiazem reverses tissue Doppler velocity abnormalities in pre-clinical hypertrophic cardiomyopathy","volume":"13","author":"McTaggart","year":"2004","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.vph.2016.09.001_bb0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejheart.2005.07.012","article-title":"Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy","volume":"8","author":"Westermann","year":"2006","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.vph.2016.09.001_bb0050","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/00498250903518228","article-title":"Impaired tissue clearance of verapamil in rat cardiac hypertrophy results in transcriptional repression of ion channels","volume":"40","author":"Zwadlo","year":"2010","journal-title":"Xenobiotica"},{"key":"10.1016\/j.vph.2016.09.001_bb0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.taap.2005.10.012","article-title":"Nifedipine represses ion channels, transporters and Ca(2+)-binding proteins in hearts of spontaneously hypertensive rats","volume":"213","author":"Zwadlo","year":"2006","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.vph.2016.09.001_bb0060","doi-asserted-by":"crossref","first-page":"14863","DOI":"10.1073\/pnas.95.25.14863","article-title":"Cluster analysis and display of genome-wide expression patterns","volume":"95","author":"Eisen","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.vph.2016.09.001_bb0065","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model","volume":"109","author":"Semsarian","year":"2002","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2016.09.001_bb0070","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bcp.2003.09.016","article-title":"Preservation of mitochondrial function during ischemia as a possible mechanism for cardioprotection of diltiazem against ischemia\/reperfusion injury","volume":"67","author":"Takeo","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.vph.2016.09.001_bb0075","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.acvd.2008.05.005","article-title":"Brain natriuretic peptide secretion in adult rat heart muscle cells: the role of calcium channels","volume":"101","author":"Nader","year":"2008","journal-title":"Arch. Cardiovasc. Dis."},{"issue":"Suppl 1","key":"10.1016\/j.vph.2016.09.001_bb0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1023\/A:1007785328325","article-title":"Treatment of angina pectoris with calcium antagonists: long-term follow-up","volume":"12","author":"Behar","year":"1998","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.vph.2016.09.001_bb0085","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0140-6736(01)06411-X","article-title":"Cardiovascular protection and blood pressure reduction: a meta-analysis","volume":"358","author":"Staessen","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2016.09.001_bb0090","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S1043661802002360","article-title":"Selectivity of different calcium antagonists on T- and L-type calcium currents in guinea-pig ventricular myocytes","volume":"46","author":"De Paoli","year":"2002","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.vph.2016.09.001_bb0095","first-page":"2877","article-title":"Clinical use of calcium entry blockers","volume":"40","author":"Flaim","year":"1981","journal-title":"Fed. Proc."}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116302385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189116302385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T12:24:51Z","timestamp":1536409491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189116302385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":19,"alternative-id":["S1537189116302385"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2016.09.001","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene expression profiling of calcium-channel antagonists in the heart of hypertensive and normotensive rats reveals class specific effects","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2016.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}